Skip to content

Lucid Diagnostics LUCD Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin-959.6%+185pp-1,054.8%+4.8pp-1,091.3%-13.9pp-1,099.5%+73.2pp-1,144.2%+363pp
Net margin-876.7%+605pp-1,232.7%-185pp-1,211.3%-141pp-1,267.4%-39.6pp-1,481.5%+95.1pp
Efficiency
Asset turnover0.2×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×+0.1×
Liquidity
Current ratio1.1×+0.3×1.3×+0.2×1.9×+0.7×1.1×-0.6×0.8×-0.6×
Leverage
Debt-to-equity0.4×0.2×-0.3×0.1×-0.4×0.3×+0.1×
Valuation
Market capitalization$204.13M+58.5%$142.9M+194%$102.91M+162%$128.75M+249%$135.22M+294%
Price / sales39.8×+10.2×30.4×+19.2×23.4×+14.0×29.5×+19.8×32.4×+20.9×
Price / book51×+34.7×13.1×+4.1×-2.2×16.4×+14.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Lucid Diagnostics's profit margins?
Lucid Diagnostics (LUCD) runs a -66.8% gross margin and a -959.6% operating margin, with a -876.7% net margin.
Where do Lucid Diagnostics's ratios come from?
Every ratio is computed from Lucid Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.